{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:50:56Z","timestamp":1794725456405,"version":"4.9.1"},"reference-count":14,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T00:00:00Z","timestamp":1115164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> Susceptibility to Graves\u2019 disease (GD) is to a significant extent determined by genetic factors of which the best known are those associated with the <jats:italic>HLA<\/jats:italic> and the <jats:italic>CTLA4<\/jats:italic> locus. Recently, two studies on British Caucasians reported that a single nucleotide polymorphism, 1858 C&gt;T in <jats:italic>PTPN22<\/jats:italic>, encoding Arg620Trp in the lymphoid protein tyrosine phosphatase (LYP), which is a negative regulator of T\u2010cell activation, increases the risk of GD. The purpose of our study was to investigate whether the <jats:italic>PTPN22<\/jats:italic>\u2018T\u2019 allele is associated with GD and\/or its subsets, defined by clinical or genetic parameters, in a Polish population.<\/jats:p><jats:p><jats:bold>Subjects and design\u2002<\/jats:bold> A cohort of 290 patients and 310 controls was genotyped using a PCR\u2010RFLP method. The distribution of <jats:italic>PTPN22<\/jats:italic> alleles and genotypes among patients and controls was compared, and correlation was sought between <jats:italic>PTPN22<\/jats:italic>\u2018T\u2019 and sex, tobacco smoking status, family history of GD, age of disease onset, presence (and severity) of ophthalmopathy, and presence of the <jats:italic>CTLA4\u00a0A49G<\/jats:italic> or <jats:italic>DRB1*03<\/jats:italic> alleles.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Association between GD and the <jats:italic>PTPN22<\/jats:italic>\u2018T\u2019 allele was confirmed (OR 1\u00b77, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b70008). Furthermore, a significant correlation between the <jats:italic>PTPN22<\/jats:italic> genotype and the age of GD onset was demonstrated (<jats:italic>r<\/jats:italic>\u00a0=\u00a0\u22120.18, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b70019). The <jats:italic>PTPN22<\/jats:italic>\u2018TT\u2019 and \u2018CC\u2019 genotypes defined groups characterized by more than twofold difference in median age of disease onset (20\u00b78\u00a0years <jats:italic>vs.<\/jats:italic> 42\u00a0years, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7003) whereas the \u2018CT\u2019 genotype was associated with an intermediate value (35\u00a0years). There were no statistically significant correlations with other analysed clinical or genetic parameters.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> We replicated the association between Graves\u2019 disease and <jats:italic>PTPN22<\/jats:italic>\u2018T\u2019 reported in British Caucasians. We also found a gene dose\u2010dependent effect of <jats:italic>PTPN22<\/jats:italic>\u2018T\u2019 on the age of onset of Graves\u2019 disease.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2005.02279.x","type":"journal-article","created":{"date-parts":[[2005,6,8]],"date-time":"2005-06-08T16:17:17Z","timestamp":1118247437000},"page":"679-682","source":"Crossref","is-referenced-by-count":105,"title":["Lymphoid tyrosine phosphatase (<i>PTPN22<\/i>\/LYP) variant and Graves\u2019 disease in a Polish population: association and gene dose\u2010dependent correlation with age of onset"],"prefix":"10.1111","volume":"62","author":[{"given":"Agata","family":"Sk\u00f3rka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Bednarczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Bar\u2010Andziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Nauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal","family":"Ploski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,5,4]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70130-4"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02424.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480013"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2004.02.033"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1108"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.11.3020"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1323"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/422827"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/423790"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/427244"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6364138"},{"key":"e_1_2_5_13_2","first-page":"136","article-title":"Epidemiology of 35delG mutation in GJB2 gene in a Polish population","volume":"10","author":"Mueller\u2010Malesinska M.","year":"2001","journal-title":"Journal of Audiological Medicine"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.3.1215"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-002-0728-0"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2005.02279.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2005.02279.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T08:59:19Z","timestamp":1697187559000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2005.02279.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,4]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1111\/j.1365-2265.2005.02279.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02279.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,4]]}}}